<DOC>
	<DOC>NCT02446717</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of ABT-493 and ABT-530 with or without ribavirin (RBV) in participants with chronic hepatitis C virus, (HCV)-infection who previously failed treatment with a direct acting antiviral (DAA)-containing regimen.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>1. Previous treatment with DAAcontaining regimen for chronic HCV infection resulting in either ontreatment virologic failure or posttreatment relapse 2. Chronic HCV GT 1, 4, 5, or 6infection 1. History of severe, lifethreatening or other significant sensitivity to any drug 2. Female who is pregnant, planning to become pregnant during the study or breastfeeding; or male whose partner is pregnant or planning to become pregnant during the study 3. Recent (within 6 months prior to study drug administration) history of drug or alcohol abuse that could preclude adherence to the protocol 4. Positive for hepatitis B surface antigen (HBsAg) or antihuman immunodeficiency virus antibody (HIV Ab) 5. Coinfection with more than one HCV genotype</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>HCV GT5</keyword>
	<keyword>Interferon (IFN) free</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>HCV Genotype 4</keyword>
	<keyword>HCV Genotype 5</keyword>
	<keyword>HCV</keyword>
	<keyword>HCV Genotype 6</keyword>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>HCV Genotype 1</keyword>
	<keyword>Chronic HCV</keyword>
	<keyword>Hepatitis C Genotype 1</keyword>
	<keyword>HCV GT4</keyword>
	<keyword>HCV GT1</keyword>
</DOC>